Management Team

Tom Wilder

President and CEO. Most recently led Sequent Medical, Inc., which was acquired by Terumo Corporation in 2016 for up to $380 million. Prior to joining Sequent, he was President and CEO of PhotoThera, Inc. Prior to this, he served as President and CEO of Micro Therapeutics, Inc. (MTIX), which was merged into ev3, Inc. (EVVV) in 2006, at a valuation of $360 million. Earlier in his career, held positions of increasing responsibility at Medtronic, Inc. (MDT). He currently serves on the Board of Directors of Penumbra, Inc. (PEN) and Endologix, Inc. (ELGX).

Jon J. Snyder

Founder, Chief Business Officer.  Over 25 years of domestic and international management leadership experience in biomedical and healthcare sales, marketing,  operations, and venture capital investment at start-up and Fortune 500 (Top 20) companies including Cyberonics, Cardinal Health, Imalux, and STERIS Corporation.

Zi-Ping Fang, Ph.D.

Chief Scientific Officer. PhD in Biomedical Engineering focused on neurostimulation technology from Case Western Reserve University. Over 25 years of neurostimulation R&D, pre-clinical and clinical research leading to FDA approval, including technology leadership and management and executive responsibility in neurostimulation startup business development and operations including Nevro and NeuroControl.